7Baggers
 NewcelX appoints ALS specialist to scientific advisory board  Investing.com Mon, 17 Nov 2025 12:54:31 GMT
 published on: 2025-11-17 02:58:28  newser.com Mon, 17 Nov 2025 08:58:28 GMT
 Published on: 2025-11-16 18:03:17  newser.com Mon, 17 Nov 2025 00:03:17 GMT
 published on: 2025-11-13 10:11:09  newser.com Thu, 13 Nov 2025 16:11:09 GMT
 published on: 2025-11-12 22:54:02  newser.com Thu, 13 Nov 2025 04:54:02 GMT
 Published on: 2025-11-12 08:50:04  newser.com Wed, 12 Nov 2025 14:50:04 GMT
 newcelx announces new cfo appointment following merger  TipRanks Fri, 07 Nov 2025 12:37:46 GMT
 published on: 2025-11-05 04:11:35  newser.com Wed, 05 Nov 2025 10:11:35 GMT

NLS Pharmaceutics Ltd.
(NASDAQ:NLSP) 

NLSP stock logo

NLS Pharmaceutics AG, a biopharmaceutical company, engages in the discovery and development of drug therapies to treat rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, a...

Founded: 2015
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends